287 filings
Page 5 of 15
424B5
115c9r 1fzcwv4kw2fnc
6 Jan 23
Prospectus supplement for primary offering
5:28pm
4
ukh lpjmam5
30 Dec 22
Athira Pharma / GLENNA MILESON ownership change
4:58pm
4
28td03juen4nayuw
6 Dec 22
Athira Pharma / Kelly A Romano ownership change
8:31pm
8-K
4d93x0 uq
18 Nov 22
Amendments to Articles of Incorporation or Bylaws
4:05pm
4
icbm7165nv
17 Nov 22
Athira Pharma / HANS MOEBIUS ownership change
7:10pm
8-K
79bl7 0otxs7
10 Nov 22
Athira Pharma Reports Third Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:11pm
4
vby6j izki6heum9z
31 Oct 22
Athira Pharma / KEVIN CHURCH ownership change
8:17pm
4
087w1min07cub
17 Oct 22
Athira Pharma / HANS MOEBIUS ownership change
6:06pm
8-K
n7aj4qqy 38hh21ror
17 Oct 22
Results support potential clinically meaningful activity of fosgonimeton without background therapy and mitigate program risk
8:30am
8-K
sj9lkk6b
15 Aug 22
Athira Pharma Reports Second Quarter 2022 Financial Results and Recent Clinical and Corporate Updates
4:35pm
SC 13D/A
tx91tu9k91h4e
1 Jul 22
Athira Pharma / PERCEPTIVE ADVISORS ownership change
4:45pm
4
pqs386 lqr2
1 Jul 22
Athira Pharma / JOSEPH EDELMAN ownership change
2:24pm
4
cve8j54na7uh 4om
30 Jun 22
Athira Pharma / HANS MOEBIUS ownership change
5:00pm
4
fvfe1cha99x lp2onfqi
24 Jun 22
Athira Pharma / Mark Worthington ownership change
7:55pm
4
hbamw50
24 Jun 22
Athira Pharma / HANS MOEBIUS ownership change
7:54pm
4
bhtjym5z
24 Jun 22
Athira Pharma / GLENNA MILESON ownership change
7:53pm
4
iogh59cyui69y8docod
24 Jun 22
Athira Pharma / Mark James Litton ownership change
7:51pm
4
f3nvh18b3do
24 Jun 22
Athira Pharma / Rachel Lenington ownership change
7:50pm